The Global Hemodialysis powder solution market is estimated to grow at CAGR 6.0% during the forecast period. Hemodialysis powder solution is primarily used to remove waste items from the blood, while preventing beneficial components from leaving the blood. It is also used to correct acid-base and electrolyte imbalances in chronic renal failure. The global hemodialysis powder solution and peritoneal dialysis market is growing, due to an increase in the prevalence of renal disorders, complications associated with kidney transplants, and the prevalence of lifestyle and chronic diseases.

The incidence of renal replacement therapy (RRT) depends on the incidence and prevalence of conditions causing end-stage renal disease (ESRD), early diagnosis of chronic kidney disease (CKD), and measures to slow progression to end-stage renal disease.. Factors such as the rising prevalence of chronic kidney disease and the rising incidence of cardiovascular disorders, both of which are significant causes of renal failure and the requirement for hemodialysis treatment, are driving the global Hemodialysis Powder Solution market. In October 2020, The Fresenius Medical Care North America (FMCNA) and Livongo Health, Inc. formed an innovative partnership to improve the lives and outcomes of people with late-stage chronic kidney disease (CKD). The companies also seek to increase optimal dialysis starts, as well as offer earlier evaluation of transplantation and home dialysis options. In addition, in 2019, CVS Health started a clinical study for its novel HemoCare Hemodialysis System, a dialysis system developed in collaboration with Segway inventor Dean Kamen for use at home.

In December 2020, after receiving marketing approval from the Food and Drug Administration (FDA), Medtronic Company launched Carpediem Cardio-Renal Paediatric Dialysis Emergency Machine in the U.S. Carpediem system can be used in acute kidney injury or fluid overloaded patients requiring hemodialysis or hemofiltration therapy. Cincinnati Children's Hospital Medical Center was the first to get the machine.

In December 2020, Diality, a privately held medical device company located in the United States,  invested about USD 12.5 million in developing a portable hemodialysis system, to meet the expanding dialysis industry's unmet technological needs.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

• Competitive Landscape- Pharmaceutical Blister Solution, WEGO, Baxter, Fresenius Kabi, Renacon Pharma, Melson Medical, Tom Medical, Rockwell Medical, and TianJin NuoDe., among others.  

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Hemodialysis powder solution market Segmentation

By Type

    • Hemodialysis Concentrates

    • Hemodialysis Dry Powder

By End User

    • Private Clinic

    • Public Hospital

    • Personal Care

    • Nursing Home

    • Others

Global Hemodialysis powder solution market by Region

North America

    • United States 

    • Canada

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• Japan

• India

• Rest of Asia-Pacific 

Rest of World

    • Latin America

    • The Middle East and Africa